PMV Pharmaceuticals (PMVP) Earnings Date, Estimates & Call Transcripts

$1.68
-0.01 (-0.59%)
(As of 01:00 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 8Estimated
Actual EPS
(Feb. 29)
-$0.31 Beat By $0.08
Consensus EPS
(Feb. 29)
-$0.39
Skip Charts & View Estimated and Actual Earnings Data

PMVP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PMVP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PMV Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.36)($0.36)($0.36)
Q2 20241($0.38)($0.38)($0.38)
Q3 20241($0.39)($0.39)($0.39)
Q4 20241($0.40)($0.40)($0.40)
FY 20244($1.53)($1.53)($1.53)

PMVP Earnings Date and Information

PMV Pharmaceuticals last issued its earnings data on February 29th, 2024. The reported ($0.31) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.08. PMV Pharmaceuticals has generated ($1.45) earnings per share over the last year (($1.45) diluted earnings per share). Earnings for PMV Pharmaceuticals are expected to decrease in the coming year, from ($1.44) to ($1.48) per share. PMV Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

PMV Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
2/29/2024Q4 2023($0.39)($0.31)+$0.08($0.31)--
11/9/2023Q3 2023($0.45)($0.34)+$0.11($0.34)--
8/9/2023Q2 2023($0.47)($0.38)+$0.09($0.38)--
5/10/2023Q1 2023($0.48)($0.42)+$0.06($0.42)--
3/1/2023Q4 2022($0.44)($0.43)+$0.01($0.43)--
11/8/2022Q3 2022($0.42)($0.40)+$0.02($0.40)--
8/9/2022Q2 2022($0.41)($0.38)+$0.03($0.38)--
5/10/2022Q1 2022($0.42)($0.41)+$0.01($0.41)--    
3/1/2022Q4 2021($0.35)($0.41)($0.06)($0.41)--
11/12/2021Q3 2021($0.30)($0.33)($0.03)($0.33)--
8/12/2021Q2 2021($0.28)($0.29)($0.01)($0.29)--
5/14/2021Q1 2021($0.26)($0.26)-($0.26)--

PMV Pharmaceuticals Earnings - Frequently Asked Questions

When is PMV Pharmaceuticals's earnings date?

PMV Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on PMVP's earnings history.

Did PMV Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, PMV Pharmaceuticals (NASDAQ:PMVP) reported ($0.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.39) by $0.08. Learn more on analysts' earnings estimate vs. PMVP's actual earnings.

How much profit does PMV Pharmaceuticals generate each year?

PMV Pharmaceuticals (NASDAQ:PMVP) has a recorded net income of -$68.96 million. PMVP has generated -$1.45 earnings per share over the last four quarters.

What is PMV Pharmaceuticals's EPS forecast for next year?

PMV Pharmaceuticals's earnings are expected to decrease from ($1.44) per share to ($1.48) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:PMVP) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners